精简细胞的生物制造潜力
Alvaro R Lara1, Marie B Andersen1, Alexander A V Madsen1
1Department of Biological and Chemical Engineering, Aarhus University, Aarhus, Denmark.
Biotechnology and bioengineering
|September 25, 2025
概括
通过去除非必不可少的基因来简化大肠杆菌,提高了代谢效率,并增强了等离子体DNA和重组蛋白质的产生. 这些工程细胞工厂为工业应用提供了重要的生物制造优势.
科学领域:
- 代谢工程是代谢工程.
- 合成生物学 合成生物学
- 生物技术是生物技术.
背景情况:
- 大肠杆菌是生物制造的劳动马.
- 减少细胞复杂性可以优化代谢途径.
- 非必要的基因和细胞外结构代表了代谢负担.
研究的目的:
- 开发精简的大肠杆菌菌株,提高代谢性能.
- 评估细胞复杂度降低对等离子体DNA和重组蛋白质生产的影响.
- 评估这些菌株在工业生物制造环境中的有用性.
主要方法:
- 通过删除细胞外结构和非必需酶的基因来改造大肠杆菌菌株.
- 评估代谢性能,包括生长速度,溢出代谢和ATP维持系数.
- 利用基因传感器监测细胞内ATP水平.
- 在批量培养中量化等离子体DNA的生产.
- 在批量和料批量条件下,在微生物反应器中评估重组蛋白表达.
主要成果:
- 精简菌株与父母菌株相比,显示出更好的代谢性能.
- 显示出更高的生长率和减少溢出代谢.
- 实现了23%的特定等离子体DNA生产率的增加.
- 在批量模式下从生物质中报告了高达82%的重组蛋白质产量.
- 在食批量模式下观察到79%的复合蛋白产量.
结论:
- 减少大肠杆菌中的细胞复杂性可以提高代谢效率.
- 精简菌株是塑体DNA和重组蛋白质生产的优质细胞工厂.
- 这些工程菌株为工业生物制造工艺提供了显著的优势.
相关概念视频
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Scale-Up Processes
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...


